Morbius may have released to a harsh Rotten Tomatoes score, but like both Venom movies, that doesn't seem to have crushed its the box office chances, as the movie met pre-release box office expectations. While Sony's recent Marvel movies haven't seen box office hauls on par with Marvel Studios' MCU films, they've still performed surprisingly well at the box office, especially considering their harsh judgment by critics.
As the last studio with rights to Marvel characters outside of Marvel Studios, Sony's Spider-Man Universe is focusing on spin-off characters about some of Spider-Man's major villains, including Venom, Morbius, and the upcoming Kraven the Hunter. While the films now have a tangential multiverse connection to the MCU, the movies mostly exist in their own continuity, although the mechanism for MCU crossovers exists should the studios agree to utilize it; however, despite their MCU adjacent status, Sony's films haven't fared nearly as well when it comes to critics and the box office.
Related: How Morbius' Rotten Tomatoes Compares to MCU & Sony's Marvel Movies
Despite the review ravaging and low Rotten Tomatoes scores, both Venom and Venom: Let There Be Carnage excelled at the box office, seemingly proving Marvel can exist on the big screen without the MCU (or good Rotten Tomatoes scores). Morbius still has a way to go before it'll be clear if it's a box office success, but there's a few things we can learn from its opening weekend box office numbers compared to Venom and the MCU.
Morbius's first-weekend box office haul of $39 million is in-line with the movie's $40 million expectations, but it's still less than half the opening weekend numbers for Venom ($80 million in 2018) and Venom: Let There Be Carnage
Read more on screenrant.com